Prinsen C F, Veerkamp J H
Department of Biochemistry, University of Nijmegen, The Netherlands.
Biochem J. 1996 Feb 15;314 ( Pt 1)(Pt 1):253-60. doi: 10.1042/bj3140253.
Human muscle fatty acid-binding protein (M-FABP) is a 15 kDa cytosolic protein which may be involved in fatty acid transfer and modulation of non-esterified fatty acid concentration in heart, skeletal muscle, kidney and many other tissues. Crystallographic studies have suggested the importance of the amino acids Thr-40, Arg-106, Arg-126 and Tyr-128 for the hydrogen bonding network of the fatty acid carboxylate group. Two phenylalanines at 16 and 57 are positioned to interact with the acyl chain of the fatty acid. We prepared 13 mutant proteins by site-directed mutagenesis and tested them for fatty acid binding and stability. Substitution of amino acids Phe-16, Arg-106 or Arg-126 created proteins which showed a large decrease in or complete loss of oleic acid binding. Substitution of Phe-57 by Ser or Val and of Tyr-128 by Phe had no great effect. The stability of the mutant proteins was tested by denaturation studies on the basis of fatty acid binding or tryptophan fluorescence and compared with that of the wild-type M-FABP. There was no direct relationship between fatty acid-binding activity and stability. Less stable mutants (F57S and Y128F) did not show a marked change in fatty acid-binding activity. Substitution of Arg-126 by Gln or Arg-106 by Thr eliminated binding activity, but the former mutant protein showed wild-type stability, in contrast to the latter. The results are in agreement with crystallographic data.
人类肌肉脂肪酸结合蛋白(M-FABP)是一种15 kDa的胞质蛋白,可能参与脂肪酸转运以及心脏、骨骼肌、肾脏和许多其他组织中非酯化脂肪酸浓度的调节。晶体学研究表明,苏氨酸-40、精氨酸-106、精氨酸-126和酪氨酸-128这些氨基酸对于脂肪酸羧基的氢键网络很重要。16位和57位的两个苯丙氨酸的位置有利于与脂肪酸的酰基链相互作用。我们通过定点诱变制备了13种突变蛋白,并测试了它们的脂肪酸结合能力和稳定性。苯丙氨酸-16、精氨酸-106或精氨酸-126被替换后产生的蛋白,其油酸结合能力大幅下降或完全丧失。将苯丙氨酸-57替换为丝氨酸或缬氨酸以及将酪氨酸-128替换为苯丙氨酸,影响不大。基于脂肪酸结合或色氨酸荧光对突变蛋白的稳定性进行变性研究测试,并与野生型M-FABP的稳定性进行比较。脂肪酸结合活性与稳定性之间没有直接关系。稳定性较差的突变体(F57S和Y128F)在脂肪酸结合活性方面没有明显变化。将精氨酸-126替换为谷氨酰胺或精氨酸-106替换为苏氨酸消除了结合活性,但与后者不同的是,前一种突变蛋白表现出野生型稳定性。结果与晶体学数据一致。